MARKET

ARAY

ARAY

Accuray
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.360
-0.010
-0.23%
After Hours: 4.230 -0.13 -2.98% 16:27 05/14 EDT
OPEN
4.190
PREV CLOSE
4.370
HIGH
4.390
LOW
4.140
VOLUME
1.38M
TURNOVER
--
52 WEEK HIGH
6.02
52 WEEK LOW
1.750
MARKET CAP
406.62M
P/E (TTM)
87.90
1D
5D
1M
3M
1Y
5Y
Walthausen & Co., LLC Buys Commercial Metals Co, Signet Jewelers, Tennant Co, Sells Miller ...
GuruFocus News · 2d ago
8-K: ACCURAY INC
(EDGAR Online via COMTEX) -- ACCURAY INC false 0001138723 0001138723 2021-05-06 2021-05-06 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C....
Edgar Online - (EDK = 8-Ks/S1/S-4) · 4d ago
Radiotherapy Device Market Perspective, Comprehensive Analysis and Forecast 2021 - 2028 By Ameco Research
pune, India, Wed, 12 May 2021 02:17:09 / Comserve Inc. / -- Radiotherapy Device Market - New Research Report Announced with business priorities in order to...
Comserve · 4d ago
Stroke Assistive Devices Market In-Depth Analysis on Size, Cost Structure and Prominent Key Players- Bioxtreme Robotics Rehabilitation, Accuray, Inc., Health Robotics S.R.L., Ekso Bionics Holdings, Inc., and Others.
May 11, 2021 (MARKITWIRED via COMTEX) -- An assistive device, commonly, is a medical equipment that assists a disabled person or patients having inability to...
Markitwired · 4d ago
Oncology Devices Global Market Report 2021: COVID 19 Growth And Change to 2030
New York, May 10, May 10, 2021 (GLOBE NEWSWIRE via COMTEX) -- New York, May 10, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report...
GlobeNewswire · 6d ago
Radiology Treatment Equipment Market Size 2021 Global Trend, Top Manufacturers, Regions Analysis and Leading 20 Countries and Forecast by 2027
May 10, 2021 (The Expresswire) -- Global “Radiology Treatment Equipment Market” report provides a detailed qualitative analysis of the Radiology Treatment...
The Express Wire · 6d ago
Robotic Surgery System Market 2021 to Experience Post-Lockdown Growth with Lucrative CAGR by 2029 | Intuitive Surgical, Inc., Cottage Health, Titan Medicals Market.biz
May 10, 2021 (WiredRelease via Comtex) -- Market.biz Research has announced the addition of a report, titled Global Robotic Surgery System Market...
marketresearch.biz · 6d ago
Global Stationary CT Scanner Market Size, Share, Value, and Competitive Landscape 2024
May 09, 2021 (Heraldkeepers) -- Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values and regional...
Heraldkeepers · 6d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ARAY. Analyze the recent business situations of Accuray through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ARAY stock price target is 8.25 with a high estimate of 10.00 and a low estimate of 7.00.
EPS
Institutional Holdings
Institutions: 186
Institutional Holdings: 71.76M
% Owned: 76.95%
Shares Outstanding: 93.26M
TypeInstitutionsShares
Increased
29
4.09M
New
13
874.25K
Decreased
31
3.47M
Sold Out
4
154.23K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.10%
Healthcare Equipment & Supplies
+1.17%
Key Executives
Chairman/Director
Louis Lavigne
President/Chief Executive Officer/Director
Joshua Levine
Chief Financial Officer/Senior Vice President
Shig Hamamatsu
Chief Financial Officer/Senior Vice President
Shigeyuki Hamamatsu
Senior Vice President/Chief Administrative Officer
Patrick Spine
Senior Vice President/General Counsel/Secretary
Jesse Chew
Senior Vice President
Jim Dennison
Senior Vice President
Suzanne Winter
Director
Byron Scott
Independent Director
Elizabeth Davila
Independent Director
James Hindman
Independent Director
Beverly Huss
Independent Director
Anne Le Grand
Independent Director
Richard Pettingill
Independent Director
Joseph Whitters
No Data
  • All
  • Financials
  • Insiders
More
About ARAY
Accuray Incorporated is a radiation oncology company. The Company develops, manufactures and markets medical devices used in radiation therapy for the treatment of cancer patients. Its products include the CyberKnife Systems, the TomoTherapy Systems, and the Radixact Delivery Treatment Platform. Its technologies, the CyberKnife and TomoTherapy Systems, are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT) and adaptive radiation therapy. The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.

Webull offers kinds of Accuray Incorporated stock information, including NASDAQ:ARAY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARAY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ARAY stock methods without spending real money on the virtual paper trading platform.